Clinical Pharmacologist

 Resonsible China Clinical Pharmacology strategy (including intensive PK, popPK, PK/PD, E-R, Immunogencitiy and QT analysis) to ensure: 1) smooth opening of late phase study in China; 2) relevant China CP regulation is fullfilled for a successful NDA registration  Serves as the clinical pharmacology representative in assigned China ASTs/IEST and TARM meetings  Serves as the (China) clinical pharmacology representative in assigned (global) study teams, to faciliate study execution  Work closely with related asset global Clin Pharm representatives in timely exchanging the relevant information and provide advise/input from the Chinese regulatory and scientific perspectives to support asset China CP strategy and study execution  Serves as the subject of expert of CP in China with close connection with global CP for professional support and collaboration  A critical reviewer and contributor for China CP documents for CTA and NDA submission, such as China PK...